SLC2A1 and neoplasm: In esophageal squamous cell carcinoma patient-derived xenografts, shikonin down-regulated p-PKM2, HK, GLUT1, and p-STAT3, glucose uptake, and lactate production, which was accompanied by suppression of tumor growth [272].